1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-28-2-73
1989-02-01
2022-08-13
Loading full text...

Full text loading...

/deliver/fulltext/jmm/28/2/medmicro-28-2-73.html?itemId=/content/journal/jmm/10.1099/00222615-28-2-73&mimeType=html&fmt=ahah

References

  1. Amyes S. G. B. 1983; The detection and incidence of transferable trimethoprim resistance. Health Bulletin 41:100–107
    [Google Scholar]
  2. Amyes S. G. B. 1986; Epidemiology of trimethoprim resistance. Journal of Antimicrobial Chemotherapy 18: Suppl C 215–221
    [Google Scholar]
  3. Amyes S. G. B., Gould I. M. 1984; Trimethoprim resistance plasmids. Annales de Microbiologiede l’Institut Pasteur 135B:177–186
    [Google Scholar]
  4. Amyes S. G. B., Smith J. T. 1974; R-factor trimethoprim resistance mechanism: an insusceptible target site. Biochemical and Biophysical Research Communications 58:412–418
    [Google Scholar]
  5. Amyes S. G. B., Smith J. T. 1976; The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388. European Journal of Biochemistry 61:597–603
    [Google Scholar]
  6. Amyes S. G. B., Young H. K. 1987; The genetics of bacterial trimethoprim resistance in tropical areas. Transactions of the Royal Society of Tropical Medicine and Hygiene 81:504–507
    [Google Scholar]
  7. Amyes S. G. B., Doherty C. J., Young H. K. 1986; High level trimethoprim resistance in urinary bacteria. European Journal of Clinical Microbiology 5:287–291
    [Google Scholar]
  8. Amyes S. G. B., Emmerson A. M., Smith J. T. 1978; R-factor mediated trimethoprim resistance: result of two three-month clinical surveys. Journal of Clinical Pathology 31:850–854
    [Google Scholar]
  9. Amyes S. G. B., McMillan C. J., Drysdale J. L. 1981; Transferable trimethoprim resistance amongst hospital isolates. In Grassi G. G., Sabath L. D. (eds) New trends in antibiotics: research and therapy Elsevier/North Holland Biomedical Press; Amsterdam: pp 325–327
    [Google Scholar]
  10. Anderson E. S. 1974; The ecological significance of R-factor activity. In Drews J., Hahn F. E. (eds) Topics in infectious diseases. I. Drug receptor interactions in antimicrobial chemotherapy Springer-Verlag; New York: pp 59–76
    [Google Scholar]
  11. Anderson E. S., Datta N. 1965; Resistance to penicillins and its transfer in Enterobacteriaceae. Lancet 1:407–409
    [Google Scholar]
  12. Archer G. L., Coughter J. P., Johnston J. L. 1986; Plasmid-encoded trimethoprim resistance in staphylococci. Antimicrobial Agents and Chemotherapy 29:733–740
    [Google Scholar]
  13. Barg N., Hutson F., Amyes S. G. B., Thomson C. J., Wharton M., Schaffher W. 1988; Two outbreaks of dysentery caused by antibiotic resistant Shigella sonnei (ARS) elaborating a type III dihydrofolate reductase (DHFR). Abstracts of the Annual Meeting of the American Society of Microbiology no. C 108
    [Google Scholar]
  14. Barth P. T., Datta N., Hedges R. W., Grinter N. J. 1976; Transposition of a deoxyribonucleic acid sequence encoding trimethoprim and streptomycin resistance from R483 to other replicons. Journal of Bacteriology 125:800–810
    [Google Scholar]
  15. Bauernfeind A., Horl G. 1987; Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. Infection 15:257–259
    [Google Scholar]
  16. Broad D. F., Smith J. T. 1982; Classification of trimethoprim-resistant dihydrofolate reductases mediated by R-plasmids using isoelectric focussing. European Journal of Biochemistry 125:617–622
    [Google Scholar]
  17. Bushby S. R. M., Hitchings G. H. 1968; Trimethoprim, a sulphonamide potentiator. British Journal of Pharmacology 33:72–90
    [Google Scholar]
  18. Coughter J. P., Johnston J. L., Archer G. L. 1987; Characterization of a staphylococcal trimethoprim resistance gene and its product. Antimicrobial Agents and Chemotherapy 31:1027–1032
    [Google Scholar]
  19. Dale J. W., Smith J. T. 1974; R-factor-mediated beta-lactamases that hydrolyze oxacillin: evidence for two distinct groups. Journal of Bacteriology 119:351–356
    [Google Scholar]
  20. Datta N., Hedges R. W. 1972; Trimethoprim resistance conferred by W plasmids in Enterobacteriaceae. Journal of General Microbiology 72:349–355
    [Google Scholar]
  21. Eliasson I., Kamme C. 1985; Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity. Journal of Antimicrobial Chemotherapy 15:139–149
    [Google Scholar]
  22. Flensberg J., Steen R. 1986; Nucleotide sequence analysis of the trimethoprim resistant dihydrofolate reductase encoded by R plasmid R751. Nucleic Acids Research 14:5933
    [Google Scholar]
  23. Fleming M. P., Datta N., Gruneberg R. N. 1972; Trimethoprim resistance determined by R factors. British Medical Journal 1:726–728
    [Google Scholar]
  24. Fling M. E., Kopf J., Richards C. 1988; Characterization of plasmid pAZl and the type III dihydrofolate reductase gene. Plasmid 19:30–38
    [Google Scholar]
  25. Fling M. E., Walton L., El well L. P. 1982; Monitoring of plasmid-encoded, trimethoprim-resistant dihydrofolate reductase genes: detection of a new resistant enzyme. Antimicrobial Agents and Chemotherapy 22:882–888
    [Google Scholar]
  26. Furth A. J. 1975; Purification and properties of a constitutive β-lactamase from Pseudomonas aeruginosa strain Dalgleish. Biochimica et Biophysica Acta 377:431–443
    [Google Scholar]
  27. Gutmann L., Kitzis M. D., Billot-Klein D., Goldstein F. W., Tran van Nhieu G., Collatz E. 1987; New plasmid mediated TEM-derived β-lactamase hydrolysing ceftazidime. Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy New York: p 187
    [Google Scholar]
  28. Hedges R. W., Datta N., Kontomichalou P., Smith J. T. 1974; Molecular specificities of R factor-determined beta-lactamases: correlation with plasmid compatibility. Journal of Bacteriology 117:56–62
    [Google Scholar]
  29. Hedges R. W., Medeiros A. A., Cohenford M., Jacoby G. A. 1985; Genetic and biochemical properties of AER-1, a novel carbenicillin hydrolyzing beta-lactamase from Aeromonas hydrophila. Antimicrobial Agents and Chemotherapy 27:479–484
    [Google Scholar]
  30. Hedges R. W., Vialard J. L., Pearson N. J., O’ Grady F. 1977; R-plasmids from Asian strains of Vibrio cholerae. Antimicrobial Agents and Chemotherapy 11:585–588
    [Google Scholar]
  31. Huovinen P. 1987; Trimethoprim resistance. Antimicrobial Agents and Chemotherapy 31:1451–1456
    [Google Scholar]
  32. Jobanputra R. A., Datta N. 1974; Trimethoprim R factors in enterobacteria from clinical specimens. Journal of Medical Microbiology 7:169–177
    [Google Scholar]
  33. Joyner S. S., Fling M. E., Stone D., Baccanari D. P. 1984; Characterization of an R-plasmid dihydrofolate reductase with a monomeric structure. Journal of Biological Chemistry 259:5851–5856
    [Google Scholar]
  34. Kliebe H., Nies B. A., Meyer J. F., Tolxdorff-Neutzling R. M., Wiedemann B. 1985; Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 28:302–307
    [Google Scholar]
  35. Labia R., Guionie M., Barthélémy M., Philippon A. 1981; Properties of three carbenicillin-hydrolysing beta-lactamases (CARB) from Pseudomonas aeruginosa: identification of a new enzyme. Journal of Antimicrobial Chemotherapy 7:49–56
    [Google Scholar]
  36. Labia R., Morand A., Tiwari K., Pitton J. S., Sirot D., Sirot J. 1988; Kinetic properties of two plasmid-mediated beta-lactamases from Klebsiella pneumoniae with strong activity against third-generation cephalosporins. Journal of Antimicrobial Chemotherapy 21:310–307
    [Google Scholar]
  37. Levesque R., Roy P. H., Letarte R., Pechere J. C. 1982; A plasmid-mediated cephalosporinase, from Achromobacter species. Journal of Infectious Diseases 145:753–761
    [Google Scholar]
  38. Livermore D. M., Jones C. S. 1986; Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates. Antimicrobial Agents and Chemotherapy 29:99–103
    [Google Scholar]
  39. Lyon B. R., May J. W., Skurray R. A. 1983; Analysis of plasmids in nosocomial strains of multiple-antibiotic-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 23:817–826
    [Google Scholar]
  40. Lyon B. R., Iuorio J. L., May J. W., Skurray R. A. 1984; Molecular epidemiology of multiresistant Staphylococcus aureus in Australian hospitals. Journal of Medical Microbiology 17:79–89
    [Google Scholar]
  41. Matthew M. 1978; Properties of the β-lactamase specified by the Pseudomonas plasmid R151. FEMS Microbiology Letters 4:241–244
    [Google Scholar]
  42. Matthew M., Sykes R. B. 1977; Properties of the beta-lactamase specified by the Pseudomonas plasmid RPL11. Journal of Bacteriology 132:341–345
    [Google Scholar]
  43. Matthew M., Harris A. M., Marshall M. J., Ross G. W. 1975; The use of analytical isoelectric focusing for detection and identification of β-lactamases. Journal of General Microbiology 88:169–178
    [Google Scholar]
  44. Matthew M., Hedges R. W., Smith J. T. 1979; Types of beta-lactamase determined by plasmids in Gram-negative bacteria. Journal of Bacteriology 138:657–662
    [Google Scholar]
  45. Medeiros A. A. 1988; β-Lactamases—past, present and future. In Livermore D. M. (ed) β-lactamases: current perspectives Theracom; Winchester: pp 1–11
    [Google Scholar]
  46. Medeiros A. A., Cohenford M., Jacoby G. A. 1985; Five novel plasmid-determined β-lactamases. Antimicrobial Agents and Chemotherapy 27:715–719
    [Google Scholar]
  47. Nandivada L. S., Amyes S. G. B. 1987; Transferable resistance to beta-lactam antibiotics in gram-negative bacteria isolated in India. Journal of Pharmacy and Pharmacology 39:18p
    [Google Scholar]
  48. Pattishall K. H., Acar J., Burchall J. J., Goldstein F. W., Harvey R. J. 1977; Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different incompatibility groups. Journal of Biological Chemistry 252:2319–2323
    [Google Scholar]
  49. Paul G., Gerbaud G., Bure A., Philippon A., Pangon Courvalin P. 1987; Transferable resistance to third-generation cephalosporins in Escherichia coli. Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy New York: p 187
    [Google Scholar]
  50. Petit A. 1988; Novel plasmid-mediated β-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 32:626–630
    [Google Scholar]
  51. Petrocheilou V., Sykes R. B., Richmond M. H. 1977; Novel R-plasmid-mediated beta-lactamase from Klebsiella aerogenes. Antimicrobial Agents and Chemotherapy 12:126–128
    [Google Scholar]
  52. Philippon A. M., Paul G. C., Thabaut A. P., Jacoby G. A. 1986; Properties of a novel carbenicillin-hydrolyzing β-lactamase (CARB-4) specified by an IncP 2 plasmid from Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 29:519–520
    [Google Scholar]
  53. Rahal K., Gerbaud G. R., Chabbert Y. A. 1973; Characterisation d’un facteur de resistance transferable de Vibrio cholera biotype eltor. Annales de Microbiologie de l’ Institut Pasteur 124B:283–294
    [Google Scholar]
  54. Reid A. J., Amyes S. G. B. 1986; Plasmid penicillin resistance in Vibrio cholerae: identification of new β-lactamase SAR-1. Antimicrobial Agents and Chemotherapy 30:245–247
    [Google Scholar]
  55. Reid A. J., Simpson I. N., Harper P. B., Amyes S. G. B. 1987; Identification and characterization of a novel β-lactamase, TLE-2, encoded by plasmid pUK702. FEMS Microbiology Letters 44:125–128
    [Google Scholar]
  56. Reid A. J., Simpson I. N., Harper P. B., Amyes S. G. B. 1988a; Cephaloridine resistance in gram-negative bacteria isolated in Scotland. Journal of Pharmacy and Pharmacology 40:571–573
    [Google Scholar]
  57. Reid A. J., Simpson I. N., Harper P. B., Amyes S. G. B. 1988b; The differential expression of genes of the PSE-4 β-lactamase in Pseudomonas aeruginosa and the Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 21:525–533
    [Google Scholar]
  58. Richmond M. H., Sykes R. B. 1973; The β-lactamases of gramnegative bacteria and their possible physiological role. In Rose A. H., Tempest D. W. (eds) Advances in microbial physiology vol 9 Academic Press; London: pp 31–88
    [Google Scholar]
  59. Roy C., Foz A., Segura C., Tirado M., Fuster E. C., Reig R. 1983; Plasmid determined beta-lactamases identified in a group of 204 ampicillin-resistant Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 12:506–510
    [Google Scholar]
  60. Rubin L. G., Medeiros A. A., Yolken R. H., Moxen E. R. 1981; Ampicillin treatment failure of apparently β-lactamasenegative Haemophilus influenzae type b meningitis due to a novel β-lactamase. Lancet 2:1008–1010
    [Google Scholar]
  61. Sawada Y., Yaginuma S., Tai M., Iyobe S., Mitsuhashi S. 1974; Resistance to β-lactam antibiotics in Pseudomonas. In Mitsubishi S., Hashimoto H. (eds) Microbial drug resistance Japan Scientific Press and University Park Press; Baltimore, Tokyo: p 39
    [Google Scholar]
  62. Shapiro J. A., Spom P. 1977; Tn402: a new transposable element determining trimethoprim resistance that inserts in bacteriophage lambda. Journal of Bacteriology 129:1632–1635
    [Google Scholar]
  63. Shlaes D. M., Medeiros A. A., Kron M. A., Currie-McCumber C., Papa E., Vartian C. V. 1986; Novel plasmid-mediated beta-lactamase in members of the family Enterobacteriaceae from Ohio. Antimicrobial Agents and Chemotherapy 30:220–224
    [Google Scholar]
  64. Simpson I. N., Harper P. B., O’ Callaghan C. H. 1980; Principal beta-lactamases responsible for resistance to beta-lactam antibiotics in urinary tract infections. Antimicrobial Agents and Chemotherapy 17:929–936
    [Google Scholar]
  65. Simpson I. N. 1983; Characterisation of a novel plasmid-mediated β-lactamase and its contribution to β-lactam resistance in Pseudomonas aeruginosa. FEMS Microbiology Letters 19:23–27
    [Google Scholar]
  66. Simpson I. N., Knothe H., Plested S. J., Harper P. B. 1986; Qualitative and quantitative aspects of beta-lactamase production as mechanisms of beta-lactam resistance in a survey of clinical isolates from faecal specimens. Journal of Antimicrobial Chemotherapy 17:125–737
    [Google Scholar]
  67. Skö O. 1988; A new enzyme for trimethoprim resistance found in Sri Lanka. Australian Society for Microbiology, Trimethoprim pamphlet p 4
    [Google Scholar]
  68. Smith S. L., Stone D., Novak P., Baccanari D. P., Burchall J. J. 1979; R plasmid dihydrofolate reductase with subunit structure. Journal of Biological Chemistry 254:6222–6225
    [Google Scholar]
  69. Stone D., Smith S. L. 1979; The amino acid sequence of the trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. Journal of Biological Chemistry 254:10857–10861
    [Google Scholar]
  70. Sundstrom L., Vinayagamoorthy T., Skold O. 1987; Novel type of plasmid-borne resistance to trimethoprim. Antimicrobial Agents and Chemotherapy 31:60–66
    [Google Scholar]
  71. Takahashi S., Tsukamoto K., Harada M., Sawai T. 1983; Carbenicillin-hydrolysing penicillinases of Proteus mirabilis and the PSE-type penicillinases of Pseudomonas aeruginosa. Microbiology and Immunology 27:995
    [Google Scholar]
  72. Tennent J. M., Young H.-K., Lyon B. R., Amyes S. G. B., Skurray R. A. 1988; Trimethoprim resistance determinants encoding a dihydrofolate reductase in clinical isolates of Staphylococcus aureus and coagulase-negative staphylococci. Journal of Medical Microbiology 26:67–73
    [Google Scholar]
  73. Thomson C. J., Amyes S. G. B. 1988; Biochemical properties of the type V plasmid-encoded trimethoprim resistant dihydrofolate reductase. Journal of Pharmacy and Pharmacology 40:19P
    [Google Scholar]
  74. Threlfall E. J., Rowe B., Huq I. 1980; Plasmid-encoded multiple antibiotic resistance in Vibrio cholerae El Tor from Bangladesh. Lancet 1:1247–1248
    [Google Scholar]
  75. Williams R. J., Livermore D. M., Lindridge M. A., Said A. A., Williams J. D. 1984; Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. Journal of Medical Microbiology 17:283–293
    [Google Scholar]
  76. Wylie B. A., Amyes S. G. B., Young H.-K., Koornhof H. J. 1988; Identification of a novel plasmid-encoded dihydrofolate reductase mediating high-level resistance to trimethoprim. Journal of Antimicrobial Chemotherapy 22:429–435
    [Google Scholar]
  77. Young H. K., Amyes S. G. B. 1983; Trimethoprim resistance: an epidemic caused by two related transposons. In Spitzy K. H., Karrer K. (eds) Proceedings of the 13th International Congress of Chemotherapy, part 87 Verlag Egermann; Vienna: pp 93–96
    [Google Scholar]
  78. Young H. K., Amyes S. G. B. 1985; Characterisation of a new transposon-mediated trimethoprim-resistant dihydrofolate reductase. Biochemical Pharmacology 34:4334–4337
    [Google Scholar]
  79. Young H. K., Amyes S. G. B. 1986a; Plasmid trimethoprim resistance in Vibrio cholerae: migration of the type I dihydrofolate reductase gene out of the Enterobacteriaceae. Journal of Antimicrobial Chemotherapy 17:697–703
    [Google Scholar]
  80. Young H. K., Amyes S. G. B. 1986b; A new mechanism of plasmid trimethoprim resistance: characterization of an inducible dihydrofolate reductase. Journal of Biological Chemistry 261:2503–2505
    [Google Scholar]
  81. Young H. K., Amyes S. G. B. 1988; Return to plasmid carriage of trimethoprim resistance in gram-negative rods. Journal of Pharmacy and Pharmacology 40:21P
    [Google Scholar]
  82. Young H. K., Jesudason M. V., Koshi G., Amyes S. G. B. 1986a; Trimethoprim resistance amongst urinary pathogens in South India. Journal of Antimicrobial Chemotherapy 17:615–621
    [Google Scholar]
  83. Young H. K., Jesudason M. V., Koshi G., Amyes S. G. B. 1986a; Unusual expression of new low-level-trimethoprim-resistance plasmids. Journal of Clinical Microbiology 24:61–64
    [Google Scholar]
  84. Young H.-K., Nandivada L. S., Amyes S. G. B The genetics of bacterial ampicillin resistance in tropical areas. Transactions of the Royal Society of Tropical Medicine and Hygiene in press
    [Google Scholar]
  85. Young H. K., Skurray R. A., Amyes S. G. B. 1987; Plasmid-mediated-trimethoprim-resistance in Staphylococcus aureus: characterization of the first gram-positive plasmid dihydrofolate reductase (type S1). Biochemical Journal 243:309–312
    [Google Scholar]
  86. Zolg J. W., Hanggi U. J. 1981; Characterization of R plasmid-associated, trimethoprim-resistant dihydrofolate reductase and determination of the nucleotide sequence of the resistance gene. Nucleic Acids Research 9:697–710
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-28-2-73
Loading
/content/journal/jmm/10.1099/00222615-28-2-73
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error